Clinical Trial Update: Radiotherapy Combined With Realgar-Indigo Naturalis Formula (RIF) in the Treatment of Rhabdomyosarcoma(RMS) in Children [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating radiotherapy combined with Realgar-Indigo Naturalis Formula for pediatric rhabdomyosarcoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhabdomyosarcoma

Drugs mentioned

• Radiotherapy
• Realgar-Indigo Naturalis Formula (realgar-indigo naturalis formula)

Snippet

Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | Conditions: Rhabdomyosarcoma, Child | Phase 2 | Status: UNKNOWN